Skip to main content
OpenTrials
Completed

NCT Number: NCT03544138

In-Office Study of the Hummingbird® in Children 6 Months-21 Years Old

The objective of this study is to evaluate the safety and performance of the Hummingbird® for the placement of ear tubes in children undergoing tympanostomy tube placement in an otolaryngology clinic using local anesthetic.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–21 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cedars-Sinai Medical Care Foundation, Beverly Hills, California, United States

Loading trial locations.

About this study

The Hummingbird Tympanostomy Tube System (H-TTS) is intended to deliver a tympanostomy tube (also referred to as a ventilation tube) through the tympanic membrane of the patient and is indicated to be used in office settings for children. The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane (TM) of the patient. It combines the separate functions of creating a myringotomy, and positioning and placing a ventilation tube across the TM.

The Hummingbird Tympanostomy Tube System (H-TTS) is a disposable surgical tool designed to deliver a tympanostomy tube ("ear tube") into the tympanic membrane of patients during a tympanostomy tube placement procedure. More than 1,000,000 ear tubes are inserted annually in the US, making it one of the most common surgical procedures performed in children.

Preceptis Medical, Inc. has developed the H-TTS to reduce trauma, pain, and risk to the patient while reducing the overall surgical procedure time. The H-TTS integrates the multiple surgical instruments necessary for current surgical procedure into a single, one-pass device. The H-TTS creates an incision in the tympanic membrane ("ear drum") and inserts a tympanostomy tube with the push of a lever. Thus, the H-TTS allows placement of a tympanostomy tube with a single pass down the ear canal. The ear tube used with the H-TTS is a standard, commercially available tympanostomy tube.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled to undergo tympanostomy tube insertion in the clinic.
  • Children 6 months to 21 years old
  • Signed parental consent, and child assent documents as applicable.
  • Parent is fluent in English.

Exclusion criteria

  • Any condition that, in the opinion of the investigator, may place the subject at greater risk (e.g., child with developmental delay).
  • Anatomy precludes sufficient visualization and access to the tympanic membrane.

Treatment and study plan

Hummingbird Tympanostomy Tube System (H-TTS)

Device

The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure.

Other names: H-TTS

Primary outcomes

  1. Rate of Ears Experiencing an Adverse Events From Enrollment to 3-10 Week Follow-up

    Time frame: Follow-up between 3-10 weeks

    AEs that occurred from enrollment through the 3-10 week follow-up were collected.

  2. Percentage of Ears With Successful Delivery of the Tympanostomy Tube by the H-TTS

    Time frame: Intra-Procedure

    Efficacy evaluation will consist of determining whether the H-TTS device successfully delivers the tympanostomy tube across the tympanic membrane.

  3. Percentage of Participants With Successful Completion of Procedure In-office

    Time frame: Intra-procedure

    Success will be defined as the ability of the surgeon to place ear tubes using the H-TTS device in the office setting with the use of local anesthetic.

Sponsors and collaborators

Lead sponsor

Preceptis Medical, Inc.

Industry

Registry information

Official study title

Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Jun 1, 2018
Registry last updated
Dec 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.